{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:32:25Z","timestamp":1791750745467,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03847-8","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T10:01:43Z","timestamp":1715335303000},"page":"302-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective analysis of thyroid incidentalomas detected by [68Ga]Ga-PSMA-11 PET\/CT"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8047-4956","authenticated-orcid":false,"given":"\u0130lkcan","family":"\u00c7er\u00e7i Ko\u00e7ar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0147-2678","authenticated-orcid":false,"given":"P\u0131nar Pelin","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-5790","authenticated-orcid":false,"given":"Zehra P\u0131nar","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-6349","authenticated-orcid":false,"given":"Mehmet","family":"S\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-5061","authenticated-orcid":false,"given":"Esen","family":"Akbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-6354","authenticated-orcid":false,"given":"Ramazan","family":"Gen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-7610","authenticated-orcid":false,"given":"Kerem","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"3847_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"M Perera","year":"2020","unstructured":"M. Perera, N. Papa, M. Roberts et al. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. Eur. Urol. 77, 403\u2013417 (2020). https:\/\/doi.org\/10.1016\/j.eururo.2019.01.049","journal-title":"Eur. Urol."},{"key":"3847_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/1097-0045(20001201)45:4<350::aid-pros10>3.0.co;2-u","volume":"45","author":"RG Lapidus","year":"2000","unstructured":"R.G. Lapidus, C.W. Tiffany, J.T. Isaacs, B.S. Slusher,, Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate. 45, 350\u2013354 (2000). https:\/\/doi.org\/10.1002\/1097-0045(20001201)45:4<350::aid-pros10>3.0.co;2-u","journal-title":"Prostate."},{"key":"3847_CR3","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.3390\/cancers14164039","volume":"14","author":"A Rizzo","year":"2022","unstructured":"A. Rizzo, S. Dall\u2019Armellina, D.A. Pizzuto et al. PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? Cancers 14, 4039 (2022). https:\/\/doi.org\/10.3390\/cancers14164039","journal-title":"Cancers"},{"key":"3847_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/ijnm.IJNM_81_18","volume":"33","author":"D Malik","year":"2018","unstructured":"D. Malik, A. Sood, B.R. Mittal et al. Nonspecific Uptake of 68Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography\/Computed Tomography Imaging: A Pictorial Assay and Review of Literature. Indian J. Nucl. Med. 33, 317\u2013325 (2018). https:\/\/doi.org\/10.4103\/ijnm.IJNM_81_18","journal-title":"Indian J. Nucl. Med."},{"key":"3847_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s42000-019-00106-8","volume":"18","author":"F Bertagna","year":"2019","unstructured":"F. Bertagna, D. Albano, L. Giovanella et al. 68Ga-PSMA PET thyroid incidentalomas. Hormones 18, 145\u2013149 (2019). https:\/\/doi.org\/10.1007\/s42000-019-00106-8","journal-title":"Hormones"},{"key":"3847_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1967\/s002449912202","volume":"23","author":"F Gossili","year":"2020","unstructured":"F. Gossili, L.J. Petersen, H.D. Zacho, The frequency of thyroid incidental findings and risk of malignancy detected by 68Ga-labeled prostate-specific membrane antigen PET\/CT in prostate cancer. Hell J. Nucl. Med. 23, 240\u2013245 (2020). https:\/\/doi.org\/10.1967\/s002449912202","journal-title":"Hell J. Nucl. Med."},{"key":"3847_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12022-017-9500-9","volume":"28","author":"M Moore","year":"2017","unstructured":"M. Moore, S. Panjwani, R. Mathew et al. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target. Endocr. Pathol. 28, 339\u2013344 (2017). https:\/\/doi.org\/10.1007\/s12022-017-9500-9","journal-title":"Endocr. Pathol."},{"key":"3847_CR8","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","volume":"48","author":"F Ceci","year":"2021","unstructured":"F. Ceci, D.E. Oprea-Lager, L. Emmett et al. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur. J. Nucl. Med. Mol. Imaging 48, 1626\u20131638 (2021). https:\/\/doi.org\/10.1007\/s00259-021-05245-y","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"3847_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000478927","volume":"6","author":"G Russ","year":"2017","unstructured":"G. Russ, S.J. Bonnema, M.F. Erdogan, C. Durante, R. Ngu, L. Leenhardt, European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur. Thyroid J. 6, 225\u2013237 (2017). https:\/\/doi.org\/10.1159\/000478927","journal-title":"Eur. Thyroid J."},{"key":"3847_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"3847_CR11","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/CMAR.S168409","volume":"10","author":"K Kaliszewski","year":"2018","unstructured":"K. Kaliszewski, D. Diakowska, B. Wojtczak, Z. Forkasiewicz, Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance\/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology. Cancer Manag. Res. 10, 2223\u20132229 (2018). https:\/\/doi.org\/10.2147\/CMAR.S168409","journal-title":"Cancer Manag. Res."},{"key":"3847_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3413\/Nukmed-0568-13-03","volume":"52","author":"G Treglia","year":"2013","unstructured":"G. Treglia, F. Bertagna, R. Sadeghi, F.A. Verburg, L. Ceriani, L. Giovanella, Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk. Nuklearmedizin 52, 130\u2013136 (2013). https:\/\/doi.org\/10.3413\/Nukmed-0568-13-03","journal-title":"Nuklearmedizin"},{"key":"3847_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s12020-012-9837-2","volume":"43","author":"F Bertagna","year":"2013","unstructured":"F. Bertagna, G. Treglia, A. Piccardo et al. F18-FDG-PET\/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine 43, 678\u2013685 (2013). https:\/\/doi.org\/10.1007\/s12020-012-9837-2","journal-title":"Endocrine"},{"key":"3847_CR14","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1210\/jc.2012-2390","volume":"97","author":"F Bertagna","year":"2012","unstructured":"F. Bertagna, G. Treglia, A. Piccardo, R. Giubbini, Diagnostic and clinical significance of F-18-FDG-PET\/CT thyroid incidentalomas. J. Clin. Endocrinol. Metab. 97, 3866\u20133875 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2390","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3847_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.723394","volume":"12","author":"JF de Leijer","year":"2021","unstructured":"J.F. de Leijer, M.J.H. Metman, A. van der Hoorn et al. Focal Thyroid Incidentalomas on 18F-FDG PET\/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration. Front. Endocrinol. 12, 723394 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.723394","journal-title":"Front. Endocrinol."},{"key":"3847_CR16","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1128\/MCB.00084-06","volume":"26","author":"RE Conway","year":"2006","unstructured":"R.E. Conway, N. Petrovic, Z. Li, W. Heston, D. Wu, L.H. Shapiro, Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol. Cell Biol. 26, 5310\u20135324 (2006). https:\/\/doi.org\/10.1128\/MCB.00084-06","journal-title":"Mol. Cell Biol."},{"key":"3847_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40336-022-00537-1","volume":"11","author":"KKS God\u00ea","year":"2023","unstructured":"K.K.S. God\u00ea, F.A. Mourato, A.F.F. Sales et al. Thyroid incidentalomas in PSMA PET\/CT: a systematic review and meta-analysis. Clin. Transl. Imaging 11, 263\u2013269 (2023). https:\/\/doi.org\/10.1007\/s40336-022-00537-1","journal-title":"Clin. Transl. Imaging"},{"key":"3847_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/diagnostics13030564","volume":"13","author":"A Rizzo","year":"2023","unstructured":"A. Rizzo, M. Racca, S. Dall\u2019Armellina et al. Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review. Diagnostics 13, 564 (2023). https:\/\/doi.org\/10.3390\/diagnostics13030564","journal-title":"Diagnostics"},{"key":"3847_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05481-z","volume":"7","author":"A Bychkov","year":"2017","unstructured":"A. Bychkov, U. Vutrapongwatana, S. Tepmongkol, S. Keelawat, PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics. Sci. Rep. 7, 5202 (2017). https:\/\/doi.org\/10.1038\/s41598-017-05481-z","journal-title":"Sci. Rep."},{"issue":"8","key":"3847_CR20","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/RLU.0000000000002161","volume":"43","author":"P Verma","year":"2018","unstructured":"P. Verma, G. Malhotra, R. Agrawal, S. Sonavane, V. Meshram, R.V. Asopa, Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET\/CT. Clin. Nucl. Med. 43(8), e265\u2013e268 (2018). https:\/\/doi.org\/10.1097\/RLU.0000000000002161","journal-title":"Clin. Nucl. Med."},{"issue":"7","key":"3847_CR21","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1007\/s00259-022-05679-y","volume":"49","author":"MW Piek","year":"2022","unstructured":"M.W. Piek, L.H. de Vries, M.L. Donswijk et al. Retrospective analysis of PSMA PET\/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment\/outcome in a tertiary cancer referral center and University Medical Center. Eur. J. Nucl. Med. Mol. Imaging 49(7), 2392\u20132400 (2022). https:\/\/doi.org\/10.1007\/s00259-022-05679-y","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"3847_CR22","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s00330-023-09492-5","volume":"33","author":"ML Donswijk","year":"2023","unstructured":"M.L. Donswijk, M.W. Piek, Z. Cheung et al. Incidence of PSMA PET thyroid incidentaloma depends on analysis method and tracer. Eur. Radiol. 33, 3377\u20133385 (2023). https:\/\/doi.org\/10.1007\/s00330-023-09492-5","journal-title":"Eur. Radiol."},{"key":"3847_CR23","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2967\/jnumed.117.190215","volume":"58","author":"MM Osman","year":"2017","unstructured":"M.M. Osman, A. Iravani, R.J. Hicks, M.S. Hofman, Detection of Synchronous Primary Malignancies with 68Ga-Labeled Prostate-Specific Membrane Antigen PET\/CT in Patients with Prostate Cancer: Frequency in 764 Patients. J. Nucl. Med. 58, 1938\u20131942 (2017). https:\/\/doi.org\/10.2967\/jnumed.117.190215","journal-title":"J. Nucl. Med."},{"key":"3847_CR24","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1210\/jc.2003-030465","volume":"88","author":"KW Kang","year":"2003","unstructured":"K.W. Kang, S.K. Kim, H.S. Kang et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J. Clin. Endocrinol. Metab. 88, 4100\u20134104 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030465","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3847_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MNM.0000000000000495","volume":"37","author":"\u00d6 Demir","year":"2016","unstructured":"\u00d6. Demir, N. K\u00f6se, E. \u00d6zkan, U. \u00dcnl\u00fct\u00fcrk, G. Aras, M.F. Erdo\u011fan, Clinical significance of thyroid incidentalomas identified by 18F-FDG PET\/CT: correlation of ultrasonograpy findings with cytology results. Nucl. Med. Commun. 37, 715\u2013720 (2016). https:\/\/doi.org\/10.1097\/MNM.0000000000000495","journal-title":"Nucl. Med. Commun."},{"key":"3847_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cen.13819","volume":"89","author":"P Trimboli","year":"2018","unstructured":"P. Trimboli, G. Paone, G. Treglia et al. Fine-needle aspiration in all thyroid incidentalomas at 18 F-FDG PET\/CT: Can EU-TIRADS revise the dogma? Clin. Endocrinol. 89, 642\u2013648 (2018). https:\/\/doi.org\/10.1111\/cen.13819","journal-title":"Clin. Endocrinol."},{"key":"3847_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/cen.13949","volume":"90","author":"P Trimboli","year":"2019","unstructured":"P. Trimboli, A. Piccardo, M. Alevizaki et al. Dedicated neck 18 F-FDG PET\/CT: An additional tool for risk assessment in thyroid nodules at ultrasound intermediate risk. Clin. Endocrinol. 90, 737\u2013743 (2019). https:\/\/doi.org\/10.1111\/cen.13949","journal-title":"Clin. Endocrinol."},{"key":"3847_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/thy.2017.0560","volume":"28","author":"SR Chung","year":"2018","unstructured":"S.R. Chung, Y.J. Choi, C.H. Suh et al. Thyroid Incidentalomas Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan. Thyroid 28, 762\u2013768 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0560","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03847-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:37:27Z","timestamp":1727761047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03847-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03847-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Patients gave informed consent to these investigations (as part of their normal medical care both at diagnosis and follow-up). The study was approved by the ethics committee of our institution (Decision date: 09.11.2022 No: 2022\/744).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}